Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6066370 | Journal of Allergy and Clinical Immunology | 2014 | 9 Pages |
Abstract
In patients with DOCK8 deficiency, only certain combinations of germline mutations supported secondary somatic repair. Those patients had an ameliorated disease course with longer survival but still had fatal complications or required hematopoietic cell transplantation. These observations support the concept that some DOCK8-immunodeficient patients have mutable mosaic genomes that can modulate disease phenotype over time.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Huie PhD, Qian MD, Yu PhD, Brenna J. PhD, Christopher G. BS, Erwin W. MD, T. Prescott MD, PhD, Gulbu MD, Helen F. RN, Peter J. MD, David B. MD, Fotini D. MD, I. Celine MD, Ashish R. MD, PhD, Raif S. MD, Daniel C. MD, PhD, Steven M. MD, Alexandra F. MD,